target_chembl_id,target_organism,document_journal,document_year,activity_id,standard_type,molecule_pref_name,target_pref_name,assay_chembl_id,bao_format,pchembl_value,assay_description
CHEMBL3663,Homo sapiens,Bioorg. Med. Chem. Lett.,1998,261295,IC50,DACTINOMYCIN,Growth factor receptor-bound protein 2,CHEMBL677054,BAO_0000357,5.3,Inhibition of GST-Grb2 Tyrosine kinase SH2 domain binding to [3H]labeled-phosphopeptide (Ac-SpYVNK-NH-C(O)-CH2CH2H3)
CHEMBL382,Homo sapiens,J. Med. Chem.,2002,351830,IC50,DACTINOMYCIN,CCRF-CEM,CHEMBL652488,BAO_0000219,9.0,Antitumor activity against human acute T-lymphoblastic leukemia CCRF-CEM cells
CHEMBL614542,Homo sapiens,J. Med. Chem.,2002,351831,IC50,DACTINOMYCIN,CCRF-SB,CHEMBL651473,BAO_0000219,8.7,Antitumor activity against human acute B-lymphoblastic leukemia CCRF-SB cells
CHEMBL388,Homo sapiens,J. Med. Chem.,2002,351832,IC50,DACTINOMYCIN,MT4,CHEMBL707806,BAO_0000219,9.0,Antitumor activity against human CD4+T cells expressing the TAT gene of HTLV-1 MT-4 cells
CHEMBL399,Homo sapiens,J. Med. Chem.,2002,351833,IC50,DACTINOMYCIN,HeLa,CHEMBL878301,BAO_0000219,8.1,Antitumor activity against cervix carcinoma Hela cells cells
CHEMBL614735,Homo sapiens,J. Med. Chem.,2002,351834,IC50,DACTINOMYCIN,HEp-2,CHEMBL693626,BAO_0000219,8.4,Antitumor activity against larynx carcinoma Hep-2 cells
CHEMBL612810,Homo sapiens,J. Med. Chem.,2002,351835,IC50,DACTINOMYCIN,WIL2-NS,CHEMBL822286,BAO_0000219,8.52,Anti tumor activity against human splenic B-lympho blastoid Wil2-NS cells
CHEMBL614628,Homo sapiens,J. Med. Chem.,2002,351836,IC50,DACTINOMYCIN,Raji,CHEMBL770638,BAO_0000219,8.7,Antitumor activity against human Burkitt lym phoma Raji cells
CHEMBL614177,Homo sapiens,J. Med. Chem.,2002,351837,IC50,DACTINOMYCIN,MOLT-4,CHEMBL714274,BAO_0000219,9.0,Antitumor activity against human acute T-lymphoblastic leukemia MOLT-4 cells
CHEMBL614533,Homo sapiens,J. Med. Chem.,2002,351838,IC50,DACTINOMYCIN,C8166,CHEMBL654817,BAO_0000219,9.1,Antitumor activity against CD+ human acute T-lymphoblastic leukemia C8166 cells
CHEMBL388,Homo sapiens,J. Med. Chem.,2002,351839,IC50,DACTINOMYCIN,MT4,CHEMBL715138,BAO_0000219,9.0,Antitumor activity against CD+ human acute T-lymphoblastic leukemia MT-4 cells
CHEMBL614919,Homo sapiens,J. Med. Chem.,2002,351840,IC50,DACTINOMYCIN,SK-MEL-28,CHEMBL805662,BAO_0000219,8.7,Antitumor activity against human skin melanoma SKMEK-28 cells
CHEMBL614036,Homo sapiens,J. Med. Chem.,2002,351841,IC50,DACTINOMYCIN,G-361,CHEMBL679418,BAO_0000219,9.0,Antitumor activity against human skin melanoma G-361 cells
CHEMBL387,Homo sapiens,J. Med. Chem.,2002,351842,IC50,DACTINOMYCIN,MCF7,CHEMBL715118,BAO_0000219,8.22,Antitumor activity against human breast adenocarcinoma MCF-7 cells
CHEMBL614923,Homo sapiens,J. Med. Chem.,2002,351843,IC50,DACTINOMYCIN,SK-MES-1,CHEMBL805668,BAO_0000219,8.4,Antitumor activity against human lung squamous carcinoma SK-MES-1 cells
CHEMBL395,Homo sapiens,J. Med. Chem.,2002,351844,IC50,DACTINOMYCIN,HepG2,CHEMBL696821,BAO_0000219,8.0,Antitumor activity against human hepatocellular carcinoma HepG2 cells
CHEMBL614519,Homo sapiens,J. Med. Chem.,2002,351845,IC50,DACTINOMYCIN,ACHN,CHEMBL623594,BAO_0000219,8.3,Antitumor activity against human renal adenocarcinoma ACHN cells
CHEMBL612565,Homo sapiens,J. Med. Chem.,2002,351846,IC50,DACTINOMYCIN,5637,CHEMBL618432,BAO_0000219,8.52,Antitumor activity against human bladder carcinoma 5637 cells
CHEMBL384,Homo sapiens,J. Med. Chem.,2002,351847,IC50,DACTINOMYCIN,HT-29,CHEMBL693869,BAO_0000219,8.22,Antitumor activity against human colon adenocarcinoma HT-29 cells
CHEMBL613508,Homo sapiens,J. Med. Chem.,2002,351848,IC50,DACTINOMYCIN,DU-145,CHEMBL669288,BAO_0000219,8.1,Antitumor activity against human prostate carcinoma DU145 cells
CHEMBL614151,None,J. Med. Chem.,2002,351850,IC50,DACTINOMYCIN,CRL-7065 cell line,CHEMBL653613,BAO_0000219,8.15,Antitumor activity against human foreskin fibroblasts CRL7065 cells
CHEMBL612558,None,J. Med. Chem.,2002,351854,IC50,DACTINOMYCIN,ADMET,CHEMBL700543,BAO_0000219,8.3,Compound concentration required to reduce the cell proliferation of Wild type and Drug- resistant human nasopharyngeal carcinoma KB cells by 50%
CHEMBL612558,None,J. Med. Chem.,2002,351855,IC50,DACTINOMYCIN,ADMET,CHEMBL702225,BAO_0000019,6.7,Compound concentration required to reduce the cell proliferation of Wild type and Drug- resistant KB subclones passaged in the presence of doxorubicin 0.09 uM by 50%
CHEMBL612558,None,J. Med. Chem.,2002,351856,IC50,DACTINOMYCIN,ADMET,CHEMBL700544,BAO_0000019,6.7,Compound concentration required to reduce the cell proliferation of Wild type and drug-resistant KB subclones passaged in the presence of etoposide 7 uM by 50%
CHEMBL612558,None,J. Med. Chem.,2002,351857,IC50,DACTINOMYCIN,ADMET,CHEMBL705969,BAO_0000019,7.3,Effect on the proliferation Wild -type and Drug- resistant KB subclones passaged uM
CHEMBL398,Homo sapiens,J. Med. Chem.,2004,578346,IC50,DACTINOMYCIN,KB,CHEMBL702198,BAO_0000219,8.4,Concentration required to reduce proliferation of KB human nasopharyngeal carcinoma (KBWT) cell line by 50% as determined by the MTT method
CHEMBL398,Homo sapiens,J. Med. Chem.,2004,578347,IC50,DACTINOMYCIN,KB,CHEMBL701391,BAO_0000219,6.7,Concentration required to reduce proliferation of KB subclones passaged in the presence of doxorubicin 0.09 uM (KBMDR) cell line by 50% as determined by the MTT method
CHEMBL398,Homo sapiens,J. Med. Chem.,2004,578348,IC50,DACTINOMYCIN,KB,CHEMBL703879,BAO_0000219,6.7,Concentration required to reduce proliferation of KB subclones passaged in the presence of etoposide 7 uM (KB7D) cell line by 50% as determined by the MTT method
CHEMBL398,Homo sapiens,J. Med. Chem.,2004,578349,IC50,DACTINOMYCIN,KB,CHEMBL703880,BAO_0000219,7.3,Concentration required to reduce proliferation of KB subclones passaged in the presence of vincristine 0.02 uM (KB7D) cell line by 50% as determined by the MTT method
CHEMBL372,Homo sapiens,J. Med. Chem.,2000,874605,IC50,DACTINOMYCIN,Homo sapiens,CHEMBL823293,BAO_0000218,8.35,Inhibitory concentration was evaluated on human Jurkat T-cells after their exposure for 48 hours
CHEMBL397,Homo sapiens,J. Med. Chem.,1999,955101,IC50,DACTINOMYCIN,Jurkat,CHEMBL704799,BAO_0000219,8.35,Inhibitory concentration against Human Jurkat T cells
CHEMBL4830,Mus musculus,Bioorg. Med. Chem. Lett.,2000,1007095,IC50,DACTINOMYCIN,Growth factor receptor-bound protein 2,CHEMBL686439,BAO_0000219,5.3,In vitro binding assay of Shc-derived phosphopeptide to Growth factor receptor bound protein 2 SH2 in B104-1-1 cells was determined
CHEMBL382,Homo sapiens,J. Med. Chem.,2003,1048835,IC50,DACTINOMYCIN,CCRF-CEM,CHEMBL656072,BAO_0000219,5.8,Cytotoxicity in human leukemic CCRF-CEM cells.
CHEMBL386,Mus musculus,J. Med. Chem.,1988,1076048,IC50,DACTINOMYCIN,L1210,CHEMBL702137,BAO_0000219,6.42,"Inhibition of synthesis of [methyl-14C] thymidine into DNA, in L1210 cells."
CHEMBL386,Mus musculus,J. Med. Chem.,1988,1076049,IC50,DACTINOMYCIN,L1210,CHEMBL702136,BAO_0000219,7.72,Inhibition of synthesis of [5-3H]-uridine into RNA in L1210 cells.
CHEMBL389,Mus musculus,J. Med. Chem.,1988,1134282,IC50,DACTINOMYCIN,P388,CHEMBL759250,BAO_0000219,5.96,50% inhibition of incorporation of precursor [3H]thymidine into DNA P388 cell lines
CHEMBL389,Mus musculus,J. Med. Chem.,1988,1134283,IC50,DACTINOMYCIN,P388,CHEMBL759251,BAO_0000219,7.3,50% inhibition of incorporation precursor [14C]uridine into RNA P388 cell lines
CHEMBL384,Homo sapiens,J. Med. Chem.,1988,1134284,IC50,DACTINOMYCIN,HT-29,CHEMBL692886,BAO_0000219,6.05,50% inhibition of incorporationf precursor [3H]thymidine into DNA HT-29 cell lines
CHEMBL384,Homo sapiens,J. Med. Chem.,1988,1134285,IC50,DACTINOMYCIN,HT-29,CHEMBL857633,BAO_0000219,7.0,50% inhibition of incorporationf precursor [3H]thymidine into RNA HT-29 cell lines
CHEMBL3879801,None,J. Med. Chem.,2002,1191384,IC50,DACTINOMYCIN,NON-PROTEIN TARGET,CHEMBL822282,BAO_0000219,8.52,Antitumor activity against human splenic B-lymphoblastoid Wil-NS cells.
CHEMBL614628,Homo sapiens,J. Med. Chem.,2002,1191385,IC50,DACTINOMYCIN,Raji,CHEMBL769234,BAO_0000219,8.7,Antitumor activity against human Burkitt lymphoma Raji cells.
CHEMBL614177,Homo sapiens,J. Med. Chem.,2002,1191386,IC50,DACTINOMYCIN,MOLT-4,CHEMBL714273,BAO_0000219,9.0,Antitumor activity against human acute T-lymphoblastic MOLT-4 leukemia cells.
CHEMBL614533,Homo sapiens,J. Med. Chem.,2002,1191387,IC50,DACTINOMYCIN,C8166,CHEMBL654818,BAO_0000219,10.1,Antitumor activity against CD4+ human acute T-lymphoblastic C8166 leukemia cells.
CHEMBL388,Homo sapiens,J. Med. Chem.,2002,1191388,IC50,DACTINOMYCIN,MT4,CHEMBL715139,BAO_0000219,9.05,Antitumor activity against CD4+ human acute T-lymphoblastic MT-4 leukemia cells.
CHEMBL614542,Homo sapiens,J. Med. Chem.,2002,1191389,IC50,DACTINOMYCIN,CCRF-SB,CHEMBL651472,BAO_0000219,9.0,Antitumor activity against human acute B-lymphoblastic CCRF-SB leukemia cells.
CHEMBL382,Homo sapiens,J. Med. Chem.,2002,1191390,IC50,DACTINOMYCIN,CCRF-CEM,CHEMBL652487,BAO_0000219,8.52,Antitumor activity against human acute T-lymphoblastic CCRF-CEM leukemia cells.
CHEMBL614036,Homo sapiens,J. Med. Chem.,2002,1191391,IC50,DACTINOMYCIN,G-361,CHEMBL679419,BAO_0000219,9.0,Antitumor activity against human skin melanoma G361 cells.
CHEMBL387,Homo sapiens,J. Med. Chem.,2002,1191392,IC50,DACTINOMYCIN,MCF7,CHEMBL715971,BAO_0000219,8.22,Antitumor activity against human breast adenocarcinoma MCF-7 cells.
CHEMBL395,Homo sapiens,J. Med. Chem.,2002,1191393,IC50,DACTINOMYCIN,HepG2,CHEMBL696820,BAO_0000219,8.0,Antitumor activity against human hepatocellular carcinoma HepG-2 cells.
CHEMBL614519,Homo sapiens,J. Med. Chem.,2002,1191394,IC50,DACTINOMYCIN,ACHN,CHEMBL621833,BAO_0000219,8.3,Antitumor activity against human renal adenocarcinoma ACHN cells.
CHEMBL612565,Homo sapiens,J. Med. Chem.,2002,1191395,IC50,DACTINOMYCIN,5637,CHEMBL883799,BAO_0000219,8.52,Antitumor activity against human bladder carcinoma 5637 cells.
CHEMBL384,Homo sapiens,J. Med. Chem.,2002,1191396,IC50,DACTINOMYCIN,HT-29,CHEMBL693868,BAO_0000219,8.22,Antitumor activity against human colon adenocarcinoma HT-29 cells.
CHEMBL399,Homo sapiens,J. Med. Chem.,2002,1191397,IC50,DACTINOMYCIN,HeLa,CHEMBL872947,BAO_0000219,7.4,Antitumor activity against HeLa cervical carcinoma cells.
CHEMBL614735,Homo sapiens,J. Med. Chem.,2002,1191398,IC50,DACTINOMYCIN,HEp-2,CHEMBL693625,BAO_0000219,8.4,Antitumor activity against Hep-2 larynx carcinoma cells.
CHEMBL391,Chlorocebus aethiops,J. Med. Chem.,2006,1671682,IC50,DACTINOMYCIN,Vero,CHEMBL870620,BAO_0000219,4.96,Cytotoxicity against normal vero kidney cells by MTS assay
CHEMBL398,Homo sapiens,J. Med. Chem.,2006,1750163,IC50,DACTINOMYCIN,KB,CHEMBL867398,BAO_0000219,9.0,Antiproliferative activity against human KB cell line by MTT assay
CHEMBL612565,Homo sapiens,J. Med. Chem.,2006,1750177,IC50,DACTINOMYCIN,5637,CHEMBL867397,BAO_0000219,8.52,Antiproliferative activity against human 5637 cell line by MTT assay
CHEMBL614519,Homo sapiens,J. Med. Chem.,2006,1750193,IC50,DACTINOMYCIN,ACHN,CHEMBL867396,BAO_0000219,8.3,Antiproliferative activity against human ACHN cell line by MTT assay
CHEMBL614735,Homo sapiens,J. Med. Chem.,2006,1750210,IC50,DACTINOMYCIN,HEp-2,CHEMBL867395,BAO_0000219,8.4,Antiproliferative activity against human Hep2 cell line by MTT assay
CHEMBL399,Homo sapiens,J. Med. Chem.,2006,1750227,IC50,DACTINOMYCIN,HeLa,CHEMBL867393,BAO_0000219,7.4,Antiproliferative activity against human HeLa cells by MTT assay
CHEMBL384,Homo sapiens,J. Med. Chem.,2006,1750245,IC50,DACTINOMYCIN,HT-29,CHEMBL867392,BAO_0000219,8.22,Antiproliferative activity against human HT29 cell line by MTT assay
CHEMBL614036,Homo sapiens,J. Med. Chem.,2006,1750266,IC50,DACTINOMYCIN,G-361,CHEMBL867391,BAO_0000219,9.0,Antiproliferative activity against human G361 cell line by MTT assay
CHEMBL382,Homo sapiens,J. Med. Chem.,2006,1750284,IC50,DACTINOMYCIN,CCRF-CEM,CHEMBL867390,BAO_0000219,9.0,Antiproliferative activity against human CCRF-CEM cell line by MTT assay
CHEMBL614542,Homo sapiens,J. Med. Chem.,2006,1750302,IC50,DACTINOMYCIN,CCRF-SB,CHEMBL867389,BAO_0000219,8.7,Antiproliferative activity against human CCRF-SB cell line by MTT assay
CHEMBL388,Homo sapiens,J. Med. Chem.,2006,1750320,IC50,DACTINOMYCIN,MT4,CHEMBL867388,BAO_0000219,9.05,Antiproliferative activity against human MT4 cell line by MTT assay
CHEMBL614533,Homo sapiens,J. Med. Chem.,2006,1750337,IC50,DACTINOMYCIN,C8166,CHEMBL867387,BAO_0000219,9.1,Antiproliferative activity against human C8166 cell line by MTT assay
CHEMBL612810,Homo sapiens,J. Med. Chem.,2006,1750356,IC50,DACTINOMYCIN,WIL2-NS,CHEMBL867386,BAO_0000219,8.52,Antiproliferative activity against human Wil2-NS cells by MTT assay
CHEMBL614177,Homo sapiens,J. Med. Chem.,2006,1750374,IC50,DACTINOMYCIN,MOLT-4,CHEMBL866732,BAO_0000219,9.0,Antiproliferative activity against human MOLT4 cell line by MTT assay
CHEMBL612514,Bos taurus,Bioorg. Med. Chem. Lett.,2006,1754775,IC50,DACTINOMYCIN,Calf thymus DNA,CHEMBL871044,BAO_0000225,4.46,Ability to displace ethidium bromide from DNA
CHEMBL382,Homo sapiens,Bioorg. Med. Chem.,2008,2215752,IC50,DACTINOMYCIN,CCRF-CEM,CHEMBL970214,BAO_0000219,8.8,Cytotoxicity against human CCRF-CEM cells after 72 hrs
CHEMBL614004,Homo sapiens,J. Nat. Prod.,2005,2328887,IC50,DACTINOMYCIN,A2780,CHEMBL1004377,BAO_0000219,9.1,Cytotoxicity against human A2780 cells
CHEMBL399,Homo sapiens,J. Nat. Prod.,2005,2331577,IC50,DACTINOMYCIN,HeLa,CHEMBL1025094,BAO_0000219,7.96,Cytotoxicity against human HeLa cells in lag-phase after 48 hrs by MTT assay
CHEMBL399,Homo sapiens,J. Nat. Prod.,2005,2331578,IC50,DACTINOMYCIN,HeLa,CHEMBL1025095,BAO_0000219,9.0,Cytotoxicity against human HeLa cells in log-phase after 48 hrs by MTT assay
CHEMBL614735,Homo sapiens,J. Nat. Prod.,2005,2331579,IC50,DACTINOMYCIN,HEp-2,CHEMBL1025096,BAO_0000219,6.72,Cytotoxicity against human Hep2 cells in lag-phase after 48 hrs by MTT assay
CHEMBL614735,Homo sapiens,J. Nat. Prod.,2005,2331580,IC50,DACTINOMYCIN,HEp-2,CHEMBL1025097,BAO_0000219,8.22,Cytotoxicity against human Hep2 cells in log-phase after 48 hrs by MTT assay
CHEMBL391,Chlorocebus aethiops,J. Nat. Prod.,2005,2331581,IC50,DACTINOMYCIN,Vero,CHEMBL1025098,BAO_0000219,7.15,Cytotoxicity against african green monkey Vero cells in lag-phase after 48 hrs by MTT assay
CHEMBL391,Chlorocebus aethiops,J. Nat. Prod.,2005,2331582,IC50,DACTINOMYCIN,Vero,CHEMBL1025099,BAO_0000219,9.0,Cytotoxicity against african green monkey Vero cells in log-phase after 48 hrs by MTT assay
CHEMBL384,Homo sapiens,J. Nat. Prod.,1989,2431601,IC50,DACTINOMYCIN,HT-29,CHEMBL981345,BAO_0000219,6.65,Antiproliferative activity against human HT-29 cells after 96 hrs by MTT assay
CHEMBL389,Mus musculus,J. Nat. Prod.,1989,2431673,IC50,DACTINOMYCIN,P388,CHEMBL981350,BAO_0000219,9.7,Antiproliferative activity against mouse P388 cells after 48 hrs by MTT assay
CHEMBL384,Homo sapiens,J. Nat. Prod.,2008,2460374,IC50,DACTINOMYCIN,HT-29,CHEMBL958762,BAO_0000219,8.54,Antiproliferative activity against human HT29 cells after 48 hrs by MTT assay
CHEMBL399,Homo sapiens,J. Nat. Prod.,2008,2460378,IC50,DACTINOMYCIN,HeLa,CHEMBL958763,BAO_0000219,9.4,Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay
CHEMBL615023,Homo sapiens,J. Nat. Prod.,2008,2460382,IC50,DACTINOMYCIN,U2OS,CHEMBL958764,BAO_0000219,8.49,Antiproliferative activity against human U2OS cells after 48 hrs by MTT assay
CHEMBL614004,Homo sapiens,J. Nat. Prod.,2005,2555129,IC50,DACTINOMYCIN,A2780,CHEMBL969154,BAO_0000219,9.1,Cytotoxicity against human A2780 cells
CHEMBL364,Plasmodium falciparum,Proc. Natl. Acad. Sci. U.S.A.,2008,3023715,EC50,DACTINOMYCIN,Plasmodium falciparum,CHEMBL1040691,BAO_0000218,6.49,NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay 
CHEMBL364,Plasmodium falciparum,Proc. Natl. Acad. Sci. U.S.A.,2008,3024028,EC50,DACTINOMYCIN,Plasmodium falciparum,CHEMBL1040691,BAO_0000218,6.09,NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay 
CHEMBL364,Plasmodium falciparum,Proc. Natl. Acad. Sci. U.S.A.,2008,3033562,EC50,DACTINOMYCIN,Plasmodium falciparum,CHEMBL1040692,BAO_0000218,6.67,NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay
CHEMBL364,Plasmodium falciparum,Proc. Natl. Acad. Sci. U.S.A.,2008,3034680,EC50,DACTINOMYCIN,Plasmodium falciparum,CHEMBL1040692,BAO_0000218,6.4,NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay
CHEMBL345,None,Bioorg. Med. Chem. Lett.,2010,3206221,EC50,DACTINOMYCIN,Nucleic Acid,CHEMBL1100213,BAO_0000225,5.37,Binding affinity to calf thymus DNA assessed as decrease in ethidium bromide fluorescence by FID assay
CHEMBL387,Homo sapiens,J. Nat. Prod.,2010,3414212,IC50,DACTINOMYCIN,MCF7,CHEMBL1226011,BAO_0000219,6.99,Cytotoxicity against human MCF7 cells after 72 hrs by MTS reduction assay
CHEMBL396,Homo sapiens,J. Nat. Prod.,2010,3414230,IC50,DACTINOMYCIN,NCI-H460,CHEMBL1226012,BAO_0000219,8.1,Cytotoxicity against human NCI-H460 cells after 72 hrs by MTS reduction assay
CHEMBL613977,Homo sapiens,J. Nat. Prod.,2010,3414248,IC50,DACTINOMYCIN,SF-268,CHEMBL1226013,BAO_0000219,7.8,Cytotoxicity against human SF268 cells after 72 hrs by MTS reduction assay
CHEMBL399,Homo sapiens,Nat. Chem. Biol.,2010,3422049,IC50,DACTINOMYCIN,HeLa,CHEMBL1228354,BAO_0000219,6.58,Inhibition of transcriptional activity in human HeLa cells assessed as [3H]uridine utilization after 2 hrs by scintillation counting
CHEMBL399,Homo sapiens,Nat. Chem. Biol.,2010,3422051,IC50,DACTINOMYCIN,HeLa,CHEMBL1228353,BAO_0000219,6.28,Inhibition of protein synthesis in human HeLa cells assessed as [35S]cysteine/methionine utilization after 2 hrs by scintillation spectroscopy
CHEMBL614696,Homo sapiens,None,None,3607804,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614477,BAO_0000219,8.49,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-011. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) "
CHEMBL614696,Homo sapiens,None,None,3658055,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1613813,BAO_0000219,7.9,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-022. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) "
CHEMBL1293236,Homo sapiens,None,None,3673741,Potency,DACTINOMYCIN,ATP-dependent DNA helicase Q1,CHEMBL1613829,BAO_0000019,5.45,
CHEMBL1293236,Homo sapiens,None,None,3696439,Potency,DACTINOMYCIN,ATP-dependent DNA helicase Q1,CHEMBL1613829,BAO_0000019,4.8,
CHEMBL614696,Homo sapiens,None,None,3698456,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1613904,BAO_0000219,8.4,
CHEMBL4159,Homo sapiens,None,None,3711645,Potency,DACTINOMYCIN,Endoplasmic reticulum-associated amyloid beta-peptide-binding protein,CHEMBL1613910,BAO_0000019,4.4,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4. (Class of assay: confirmatory) "
CHEMBL5514,Homo sapiens,None,None,3751964,Potency,DACTINOMYCIN,Huntingtin,CHEMBL1613918,BAO_0000019,7.5,"PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ]"
CHEMBL614696,Homo sapiens,None,None,3768711,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614349,BAO_0000219,7.9,"PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) "
CHEMBL4261,Homo sapiens,None,None,3769507,Potency,DACTINOMYCIN,Hypoxia-inducible factor 1 alpha,CHEMBL1614399,BAO_0000019,6.6,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response. (Class of assay: confirmatory) [Related pubchem assays: 914 (Primary screen.), 915 (Primary screen.)]"
CHEMBL614696,Homo sapiens,None,None,3773582,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1613947,BAO_0000219,8.4,
CHEMBL614696,Homo sapiens,None,None,3774817,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1613950,BAO_0000219,8.6,
CHEMBL614696,Homo sapiens,None,None,3777917,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1613964,BAO_0000219,8.2,PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells. (Class of assay: confirmatory) 
CHEMBL614696,Homo sapiens,None,None,3778921,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1613967,BAO_0000219,8.2,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-020. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) "
CHEMBL612545,None,None,None,3779631,Potency,DACTINOMYCIN,Unchecked,CHEMBL1613944,BAO_0000019,4.5,"PUBCHEM_BIOASSAY: qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region. (Class of assay: confirmatory) [Related pubchem assays: 588, 593, 594, 587, 592, 590, 589, 896, 888, 591 ]"
CHEMBL1293299,Homo sapiens,None,None,3787694,Potency,DACTINOMYCIN,Histone-lysine N-methyltransferase MLL,CHEMBL1614410,BAO_0000019,4.4,PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)]
CHEMBL3468,Homo sapiens,None,None,3804152,Potency,DACTINOMYCIN,Caspase-7,CHEMBL1613779,BAO_0000019,4.5,PUBCHEM_BIOASSAY: qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7. (Class of assay: confirmatory) 
CHEMBL1293232,Homo sapiens,None,None,3879892,Potency,DACTINOMYCIN,Survival motor neuron protein,CHEMBL1613842,BAO_0000019,6.5,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) 
CHEMBL614696,Homo sapiens,None,None,3894611,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1613853,BAO_0000219,8.6,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-016. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) "
CHEMBL614696,Homo sapiens,None,None,3902869,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1613876,BAO_0000219,8.2,
CHEMBL614696,Homo sapiens,None,None,3904016,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614231,BAO_0000219,8.6,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-002. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) "
CHEMBL614696,Homo sapiens,None,None,3919730,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614356,BAO_0000219,8.0,
CHEMBL614696,Homo sapiens,None,None,3950104,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614486,BAO_0000219,8.6,
CHEMBL614696,Homo sapiens,None,None,3951361,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614492,BAO_0000219,8.49,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-008. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) "
CHEMBL3563,Trypanosoma cruzi,None,None,3977234,Potency,DACTINOMYCIN,Cruzipain,CHEMBL1613769,BAO_0000019,5.4,
CHEMBL3563,Trypanosoma cruzi,None,None,4005207,Potency,DACTINOMYCIN,Cruzipain,CHEMBL1613769,BAO_0000019,4.9,
CHEMBL1293224,Homo sapiens,None,None,4025067,Potency,DACTINOMYCIN,Microtubule-associated protein tau,CHEMBL1614421,BAO_0000357,4.6,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]"
CHEMBL614696,Homo sapiens,None,None,4057233,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614425,BAO_0000219,6.1,PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells. (Class of assay: confirmatory) 
CHEMBL614696,Homo sapiens,None,None,4078786,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614435,BAO_0000219,7.4,PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells. (Class of assay: confirmatory) 
CHEMBL1293231,Mus musculus,None,None,4096319,Potency,DACTINOMYCIN,Nuclear receptor ROR-gamma,CHEMBL1614441,BAO_0000019,4.05,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) 
CHEMBL1293231,Mus musculus,None,None,4102057,Potency,DACTINOMYCIN,Nuclear receptor ROR-gamma,CHEMBL1614441,BAO_0000019,4.7,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) 
CHEMBL614696,Homo sapiens,None,None,4106402,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614393,BAO_0000219,8.49,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-012. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) "
CHEMBL1293231,Mus musculus,None,None,4113719,Potency,DACTINOMYCIN,Nuclear receptor ROR-gamma,CHEMBL1614441,BAO_0000019,7.05,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) 
CHEMBL3577,Homo sapiens,None,None,4136863,Potency,DACTINOMYCIN,Aldehyde dehydrogenase 1A1,CHEMBL1614458,BAO_0000019,4.55,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))]
CHEMBL3577,Homo sapiens,None,None,4166080,Potency,DACTINOMYCIN,Aldehyde dehydrogenase 1A1,CHEMBL1614458,BAO_0000019,4.65,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))]
CHEMBL1293237,Homo sapiens,None,None,4280304,Potency,DACTINOMYCIN,Bloom syndrome protein,CHEMBL1614117,BAO_0000019,4.74,
CHEMBL614696,Homo sapiens,None,None,4291479,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614132,BAO_0000219,8.6,
CHEMBL614696,Homo sapiens,None,None,4371315,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614168,BAO_0000219,8.1,
CHEMBL2903,Homo sapiens,None,None,4464869,Potency,DACTINOMYCIN,Arachidonate 15-lipoxygenase,CHEMBL1614240,BAO_0000019,4.9,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase). (Class of assay: confirmatory) 
CHEMBL1293254,Equus caballus,None,None,4480495,Potency,DACTINOMYCIN,Ferritin light chain,CHEMBL1614249,BAO_0000357,4.5,
CHEMBL612545,None,None,None,4587244,Potency,DACTINOMYCIN,Unchecked,CHEMBL1614267,BAO_0000019,7.3,PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells. (Class of assay: confirmatory) 
CHEMBL1293234,Giardia intestinalis,None,None,4605320,Potency,DACTINOMYCIN,"Putative fructose-1,6-bisphosphate aldolase",CHEMBL1614275,BAO_0000019,5.15,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ]"
CHEMBL614696,Homo sapiens,None,None,4674467,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1613785,BAO_0000219,8.4,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-010. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) "
CHEMBL614696,Homo sapiens,None,None,4717874,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614528,BAO_0000219,8.4,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-018. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) "
CHEMBL614696,Homo sapiens,None,None,4723516,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614329,BAO_0000219,8.3,
CHEMBL614696,Homo sapiens,None,None,4749371,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614518,BAO_0000219,8.49,
CHEMBL1293231,Mus musculus,None,None,4778592,Potency,DACTINOMYCIN,Nuclear receptor ROR-gamma,CHEMBL1614087,BAO_0000019,7.75,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) 
CHEMBL614696,Homo sapiens,None,None,4783677,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614008,BAO_0000219,8.49,
CHEMBL4801,Homo sapiens,None,None,4831671,Potency,DACTINOMYCIN,Caspase-1,CHEMBL1614158,BAO_0000019,4.5,PUBCHEM_BIOASSAY: qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1. (Class of assay: confirmatory) 
CHEMBL612545,None,None,None,4865139,Potency,DACTINOMYCIN,Unchecked,CHEMBL1614218,BAO_0000019,7.6,PUBCHEM_BIOASSAY: MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells. (Class of assay: confirmatory) 
CHEMBL614696,Homo sapiens,None,None,4872681,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614215,BAO_0000219,8.4,
CHEMBL614696,Homo sapiens,None,None,4872897,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614216,BAO_0000219,8.49,
CHEMBL1293237,Homo sapiens,None,None,4885952,Potency,DACTINOMYCIN,Bloom syndrome protein,CHEMBL1614067,BAO_0000019,5.15,
CHEMBL614696,Homo sapiens,None,None,4896431,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614049,BAO_0000219,8.6,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-007. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) "
CHEMBL614696,Homo sapiens,None,None,4901620,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614053,BAO_0000219,8.1,
CHEMBL614696,Homo sapiens,None,None,4902098,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614072,BAO_0000219,8.6,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-014. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) "
CHEMBL614696,Homo sapiens,None,None,4976519,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614092,BAO_0000219,8.49,
CHEMBL614696,Homo sapiens,None,None,4980677,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614097,BAO_0000219,8.4,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-024. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) "
CHEMBL340,Homo sapiens,None,None,4985816,Potency,DACTINOMYCIN,Cytochrome P450 3A4,CHEMBL1614108,BAO_0000357,4.7,PUBCHEM_BIOASSAY: qHTS Assay for Activators of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ]
CHEMBL1293231,Mus musculus,None,None,4987316,Potency,DACTINOMYCIN,Nuclear receptor ROR-gamma,CHEMBL1614087,BAO_0000019,7.5,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) 
CHEMBL1293231,Mus musculus,None,None,4988125,Potency,DACTINOMYCIN,Nuclear receptor ROR-gamma,CHEMBL1614087,BAO_0000019,7.65,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) 
CHEMBL614696,Homo sapiens,None,None,5019617,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1613890,BAO_0000219,8.49,
CHEMBL614696,Homo sapiens,None,None,5022731,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1613919,BAO_0000219,7.8,
CHEMBL340,Homo sapiens,None,None,5054841,Potency,DACTINOMYCIN,Cytochrome P450 3A4,CHEMBL1613886,BAO_0000357,4.7,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ]
CHEMBL1293236,Homo sapiens,None,None,5056092,Potency,DACTINOMYCIN,ATP-dependent DNA helicase Q1,CHEMBL1613928,BAO_0000019,5.85,
CHEMBL614696,Homo sapiens,None,None,5069022,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1613942,BAO_0000219,8.49,"PUBCHEM_BIOASSAY: Cell Viability - LYMP2-006. Luminescent cell viability assay, measuring the amount of cellular ATP in the cell line following compound treatment for 24 hours (Class of assay: confirmatory) "
CHEMBL614696,Homo sapiens,None,None,5078265,Potency,DACTINOMYCIN,Lymphoblastoid cells,CHEMBL1614036,BAO_0000219,7.7,
CHEMBL391,Chlorocebus aethiops,Eur. J. Med. Chem.,2011,5177019,IC50,DACTINOMYCIN,Vero,CHEMBL1663206,BAO_0000219,4.96,Cytotoxicity against african green monkey Vero cells after 20 hrs by MTS assay
CHEMBL399,Homo sapiens,Eur. J. Med. Chem.,2012,10943304,IC50,DACTINOMYCIN,HeLa,CHEMBL2050950,BAO_0000219,8.96,Cytotoxicity against human HeLa cells assessed as cell viability after 48 hrs by MTT assay
CHEMBL392,Homo sapiens,Eur. J. Med. Chem.,2012,10943322,IC50,DACTINOMYCIN,A549,CHEMBL2050951,BAO_0000219,8.14,Cytotoxicity against human A549 cells assessed as cell viability after 48 hrs by MTT assay
CHEMBL387,Homo sapiens,Eur. J. Med. Chem.,2012,10943372,IC50,DACTINOMYCIN,MCF7,CHEMBL2050954,BAO_0000219,7.62,Cytotoxicity against human MCF7 cells assessed as cell viability after 48 hrs by MTT assay
CHEMBL391,Chlorocebus aethiops,Eur. J. Med. Chem.,2012,10943406,IC50,DACTINOMYCIN,Vero,CHEMBL2050956,BAO_0000219,7.15,Cytotoxicity against african green monkey Vero cells assessed as cell viability after 48 hrs by MTT assay
CHEMBL399,Homo sapiens,Bioorg. Med. Chem. Lett.,2014,14658913,IC50,DACTINOMYCIN,HeLa,CHEMBL3266207,BAO_0000219,8.96,Cytotoxicity against human HeLa cells in lag phase of growth after 48 hrs
CHEMBL399,Homo sapiens,Bioorg. Med. Chem. Lett.,2014,14658914,IC50,DACTINOMYCIN,HeLa,CHEMBL3266208,BAO_0000219,8.8,Cytotoxicity against human HeLa cells in log phase of growth after 48 hrs
CHEMBL3879801,None,Bioorg. Med. Chem. Lett.,2014,14658915,IC50,DACTINOMYCIN,NON-PROTEIN TARGET,CHEMBL3266209,BAO_0000219,6.77,Cytotoxicity against human Hep2 cells in lag phase of growth after 48 hrs
CHEMBL3879801,None,Bioorg. Med. Chem. Lett.,2014,14658916,IC50,DACTINOMYCIN,NON-PROTEIN TARGET,CHEMBL3266210,BAO_0000219,8.21,Cytotoxicity against human Hep2 cells in log phase of growth after 48 hrs
CHEMBL391,Chlorocebus aethiops,Bioorg. Med. Chem. Lett.,2014,14658917,IC50,DACTINOMYCIN,Vero,CHEMBL3266211,BAO_0000219,7.14,Cytotoxicity against African green monkey Vero cells in lag phase of growth after 48 hrs
CHEMBL391,Chlorocebus aethiops,Bioorg. Med. Chem. Lett.,2014,14658918,IC50,DACTINOMYCIN,Vero,CHEMBL3266212,BAO_0000219,8.0,Cytotoxicity against African green monkey Vero cells in log phase of growth after 48 hrs
CHEMBL5122,Homo sapiens,J. Med. Chem.,2015,15240097,IC50,DACTINOMYCIN,Discoidin domain-containing receptor 2,CHEMBL3424162,BAO_0000219,5.05,Inhibition of human DDR2 expressed in HEK293 cells assessed as reduction in collagen-1-induced DDR2 tyrosine phosphorylation pre-incubated for 30 mins by immunoblotting method
CHEMBL612545,None,None,None,15472665,IC50,DACTINOMYCIN,Unchecked,CHEMBL3561978,BAO_0000219,7.43,PubChem BioAssay. nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-IC50.   (Class of assay: confirmatory) 
CHEMBL612545,None,None,None,15516622,IC50,DACTINOMYCIN,Unchecked,CHEMBL3562121,BAO_0000219,8.82,PubChem BioAssay. alkaline phosphatase stimulation in WNT3A conditioned C2C12 cells-IC50.   (Class of assay: confirmatory) 
CHEMBL612545,None,None,None,15539273,IC50,DACTINOMYCIN,Unchecked,CHEMBL3562024,BAO_0000019,7.39,PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture nuclear area decrease (viability)-IC50.   (Class of assay: confirmatory) 
CHEMBL612545,None,None,None,15575951,IC50,DACTINOMYCIN,Unchecked,CHEMBL3562043,BAO_0000019,9.0,PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-IC50.   (Class of assay: confirmatory) 
CHEMBL612545,None,J Nat Prod,2016,18194952,EC50,DACTINOMYCIN,Unchecked,CHEMBL4042088,BAO_0000219,9.56,Cytotoxicity against human PC3 cells assessed as reduction in cell viability after 48 hrs by alamar blue assay
CHEMBL612545,None,J Nat Prod,2016,18194959,EC50,DACTINOMYCIN,Unchecked,CHEMBL4042089,BAO_0000219,9.7,Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by alamar blue assay
